Analysts think PODD stock price could increase by 52%
Mar 06, 2026, 12:25 PM
-15.19%
What does PODD do
Insulet, headquartered in Acton, Massachusetts, develops and markets insulin infusion systems, including the Omnipod 5 Automated Insulin Delivery System, for insulin-dependent diabetes. The company employs 3,000 staff and went public in 2007.
29 analysts think PODD stock price will increase by 52.43%. The current median analyst target is $367.20 compared to a current stock price of $240.91. The lowest analysts target is $288.86 and the highest analyst target is $456.75.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.